ANPs effect on MARCKS and StAR phosphorylation in agonist-stimulated glomerulosa cells

R. A. Calle, Wendy B Bollag, S. White, S. Betancourt-Calle, P. Kent

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Atrial natriuretic peptide (ANP) is a cardiac hormone that inhibits aldosterone secretion induced by all physiologic agonists. The purpose of this study is to explore ANP-induced changes in the phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS) and the steroidogenic acute regulatory protein (StAR), in AngII or K+-stimulated glomerulosa cells. The data show that ANP completely inhibits the phosphorylation of MARCKS and partially inhibits that of StAR in cells stimulated with K+. ANP also partially inhibits MARCKS phosphorylation but does not affect StAR phosphorylation in cells stimulated with AngII. These effects appear to be cGMP-independent and at least partially dependent on inhibition of protein kinase C (PKC). To our knowledge, this is the first report of ANP modulating either MARCKS or StAR phosphorylation in [32P]-labeled cells. The data also support the hypothesis that ANP inhibits aldosterone secretion acting as a step involved in cholesterol transport to the mitochondria.

Original languageEnglish (US)
Pages (from-to)71-79
Number of pages9
JournalMolecular and Cellular Endocrinology
Volume177
Issue number1-2
DOIs
StatePublished - May 25 2001

Fingerprint

Phosphorylation
Atrial Natriuretic Factor
Aldosterone
Mitochondria
Protein Kinase C
steroidogenic acute regulatory protein
myristoylated alanine-rich C kinase substrate
Cholesterol
Hormones

Keywords

  • Adrenal glomerulosa
  • Aldosterone
  • Angiotensin II
  • Myristoylated alanine-rich C-kinase substrate
  • Potassium
  • Steroidogenic acute regulatory protein

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Endocrinology

Cite this

ANPs effect on MARCKS and StAR phosphorylation in agonist-stimulated glomerulosa cells. / Calle, R. A.; Bollag, Wendy B; White, S.; Betancourt-Calle, S.; Kent, P.

In: Molecular and Cellular Endocrinology, Vol. 177, No. 1-2, 25.05.2001, p. 71-79.

Research output: Contribution to journalArticle

Calle, R. A. ; Bollag, Wendy B ; White, S. ; Betancourt-Calle, S. ; Kent, P. / ANPs effect on MARCKS and StAR phosphorylation in agonist-stimulated glomerulosa cells. In: Molecular and Cellular Endocrinology. 2001 ; Vol. 177, No. 1-2. pp. 71-79.
@article{52ecbacb02774d28bf09306891eedd54,
title = "ANPs effect on MARCKS and StAR phosphorylation in agonist-stimulated glomerulosa cells",
abstract = "Atrial natriuretic peptide (ANP) is a cardiac hormone that inhibits aldosterone secretion induced by all physiologic agonists. The purpose of this study is to explore ANP-induced changes in the phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS) and the steroidogenic acute regulatory protein (StAR), in AngII or K+-stimulated glomerulosa cells. The data show that ANP completely inhibits the phosphorylation of MARCKS and partially inhibits that of StAR in cells stimulated with K+. ANP also partially inhibits MARCKS phosphorylation but does not affect StAR phosphorylation in cells stimulated with AngII. These effects appear to be cGMP-independent and at least partially dependent on inhibition of protein kinase C (PKC). To our knowledge, this is the first report of ANP modulating either MARCKS or StAR phosphorylation in [32P]-labeled cells. The data also support the hypothesis that ANP inhibits aldosterone secretion acting as a step involved in cholesterol transport to the mitochondria.",
keywords = "Adrenal glomerulosa, Aldosterone, Angiotensin II, Myristoylated alanine-rich C-kinase substrate, Potassium, Steroidogenic acute regulatory protein",
author = "Calle, {R. A.} and Bollag, {Wendy B} and S. White and S. Betancourt-Calle and P. Kent",
year = "2001",
month = "5",
day = "25",
doi = "10.1016/S0303-7207(01)00454-3",
language = "English (US)",
volume = "177",
pages = "71--79",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - ANPs effect on MARCKS and StAR phosphorylation in agonist-stimulated glomerulosa cells

AU - Calle, R. A.

AU - Bollag, Wendy B

AU - White, S.

AU - Betancourt-Calle, S.

AU - Kent, P.

PY - 2001/5/25

Y1 - 2001/5/25

N2 - Atrial natriuretic peptide (ANP) is a cardiac hormone that inhibits aldosterone secretion induced by all physiologic agonists. The purpose of this study is to explore ANP-induced changes in the phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS) and the steroidogenic acute regulatory protein (StAR), in AngII or K+-stimulated glomerulosa cells. The data show that ANP completely inhibits the phosphorylation of MARCKS and partially inhibits that of StAR in cells stimulated with K+. ANP also partially inhibits MARCKS phosphorylation but does not affect StAR phosphorylation in cells stimulated with AngII. These effects appear to be cGMP-independent and at least partially dependent on inhibition of protein kinase C (PKC). To our knowledge, this is the first report of ANP modulating either MARCKS or StAR phosphorylation in [32P]-labeled cells. The data also support the hypothesis that ANP inhibits aldosterone secretion acting as a step involved in cholesterol transport to the mitochondria.

AB - Atrial natriuretic peptide (ANP) is a cardiac hormone that inhibits aldosterone secretion induced by all physiologic agonists. The purpose of this study is to explore ANP-induced changes in the phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS) and the steroidogenic acute regulatory protein (StAR), in AngII or K+-stimulated glomerulosa cells. The data show that ANP completely inhibits the phosphorylation of MARCKS and partially inhibits that of StAR in cells stimulated with K+. ANP also partially inhibits MARCKS phosphorylation but does not affect StAR phosphorylation in cells stimulated with AngII. These effects appear to be cGMP-independent and at least partially dependent on inhibition of protein kinase C (PKC). To our knowledge, this is the first report of ANP modulating either MARCKS or StAR phosphorylation in [32P]-labeled cells. The data also support the hypothesis that ANP inhibits aldosterone secretion acting as a step involved in cholesterol transport to the mitochondria.

KW - Adrenal glomerulosa

KW - Aldosterone

KW - Angiotensin II

KW - Myristoylated alanine-rich C-kinase substrate

KW - Potassium

KW - Steroidogenic acute regulatory protein

UR - http://www.scopus.com/inward/record.url?scp=0035947004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035947004&partnerID=8YFLogxK

U2 - 10.1016/S0303-7207(01)00454-3

DO - 10.1016/S0303-7207(01)00454-3

M3 - Article

C2 - 11377822

AN - SCOPUS:0035947004

VL - 177

SP - 71

EP - 79

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1-2

ER -